Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen

This publication has 22 references indexed in Scilit:

• Preparation, Immunogenicity, and Protective Efficacy, in a Murine Model, of a Conjugate Vaccine Composed of the Polysaccharide Moiety of the Lipopolysaccharide of Vibrio cholerae O139 Bound to Tetanus Toxoid
  Infection and Immunity, 2001
• The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old Children
  New England Journal of Medicine, 2001
• Purified Lipopolysaccharide fromFrancisella tularensisLive Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and Gamma Interferon
  Infection and Immunity, 2000
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
  The Pediatric Infectious Disease Journal, 2000
• Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine
  The Lancet, 1999
• Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production
  Molecular Microbiology, 1996
• Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism
  FEMS Immunology & Medical Microbiology, 1996
• Immunogenicity and toxicity of lipopolysaccharide fromFrancisella tularensisLVS
  FEMS Microbiology Letters, 1992
• Structure of the O-antigen of Francisella tularensis strain 15
  Carbohydrate Research, 1991
• Aerosol infection of animals with strains ofLegionella pneumophilaof different virulence: comparison with intraperitoneal and intranasal routes of infection
  Epidemiology and Infection, 1983